In Pharma Sustainability, AstraZeneca, Johnson & Johnson Rate High
On a scale of 1 to 100, AstraZeneca and Johnson & Johnson are the only pharmaceutical companies to rate above 70 in a recent survey of sustainability practices in the sector.
Other firms scoring highly are Baxter (66) and GlaxoSmithKline, Pfizer and Schering-Plough, all three of which scored 60.
Climate Counts evaluates firms’ commitments in four areas:
- whether they have measured their carbon footprint
- if they reduced their impact on global warming
- if they have supported or blocked climate legislation or policy
- to what level they have publicly disclosed their climate actions
AstraZeneca scored highly in all sectors except for policy, in which it scored a zero out of ten.
Johnson & Johnson scored highly in all sectors except for measuring its own carbon footprint, an area in which it scored 12 out of 22.
Energy Manager News
- PACE Financing Makes Progress but Still Encounters Opposition
- Grand View: Datacenter Cooling Market Worth $17.78B by 2024
- Idaho Opens First Solar Farm
- What You Need To Know About Green Insulation: Green Seal’s New Standard
- Obama Administration to Provide Up to $4.5 billion in Loan Guarantees for Electric Charging Stations
- Minnesota PUC Approves New Rate Structure, Size Cap for Solar Gardens
- Maine PUC Endorses Natural Gas Pipeline Expansion at Expense of Ratepayers
- Geothermal Heating and Cooling is Worth Another Look